masimo.com (MASI): Rentabilitas operasi

Masimo Corporation (MASI) - logo korporat

Moderate pricing power driven by patents supports an operating margin history where the value has stabilized at 19.90. Masimo Corporation (MASI) generates revenue from the sale of sensors and pulse oximeters for patient monitoring. The high cost of equipment replacement is driven by the deep integration of monitoring systems into hospital IT infrastructure, creating significant barriers for customers switching to alternative solutions.

MASI - Rasio bathi operasi Masimo ing rentang 04.07.2022 - 21.06.2026

Rincian analitis perusahaan Masimo Corporation

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:MASI, Masimo Inc.
Barang utama Masimo Inc.

Operating margin measures the share of profit from core operations before interest and taxes relative to total revenue, reflecting internal cost management efficiency. By analyzing operating margin fluctuations, an investor assesses the ability of Masimo Corporation (MASI) to monetize its pulse oximetry patents and leverage high customer switching costs to maintain premium business profitability.

Analisis pesaing

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|STVN - Rentabilitas operasi|Teleflex Inc - Rasio bathi operasi|merit.com (MMSI) - Rentabilitas operasi|Rentabilitas dodolan operasi envistaco.com (NVST)|ICUI (ICU Medical Inc) - Margin operasi|Rentabilitas dodolan operasi Dentsply Sirona Inc XRAY|Rentabilitas operasi LeMaitre Corp (LMAT)|ATRC (AtriCure Corp) - Tingkat bathi operasi|Margin operasi STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Rentabilitas dodolan operasi|ZimVie Inc - Margin operasi|Rentabilitas dodolan operasi AngioDynamics|CERS (Cerus Corp) - Margin dodolan operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi